Sleep medicine · movement disorders

RLS: the 4 criteria—and more.

Restless legs syndrome has a recognizable clinical pattern. Knowing the four signature features—and the conditions that imitate them—can turn a vague nighttime complaint into a useful diagnosis.

Hanul Bhandari, MD · August 18, 2026 · 8-minute read

Restless legs syndrome is not simply “restless sleep.” It is a neurological sensorimotor disorder defined by an urge to move, a relationship to rest, relief with movement and a strong evening or nighttime pattern.

The four signature criteria

The classic features are often remembered with the word URGE. All four should be present, and current diagnostic standards add an important fifth requirement: another condition must not better explain the symptoms.¹

Urge to move the legsThe urge is usually accompanied by uncomfortable sensations—pulling, crawling, buzzing, aching or an internal restlessness—but some people mainly notice the urge itself.

Rest brings it onSymptoms begin or worsen during inactivity, such as lying in bed, sitting through a flight, watching a movie or riding in a car.

Getting up or moving helpsWalking, stretching or moving the legs provides at least partial relief while the movement continues.

Evening or nighttime predominanceSymptoms occur only in the evening or night, or are clearly worse then than during the day.

The pattern matters more than any single word a patient uses to describe the sensation.

The “and more”: exclude the mimics

The International Restless Legs Syndrome Study Group added a fifth essential criterion because many problems can satisfy part of the pattern without truly being RLS. Leg cramps, positional discomfort, neuropathy, arthritis, venous disease, medication-induced restlessness and habitual foot movement can all look similar.¹

A nocturnal cramp is typically a painful, sustained muscle contraction rather than an internal urge. Peripheral neuropathy may burn or tingle but does not reliably improve with walking or follow a strong evening pattern. Akathisia creates a more generalized need to move and is often linked to medication exposure.

RLS is not the same as PLMS—or PLMD

RLS is diagnosed from the awake clinical history. Periodic limb movements of sleep (PLMS) are repetitive movements recorded during sleep testing. They commonly accompany RLS but may also occur without it. Periodic limb movement disorder (PLMD) is diagnosed only when those recorded movements are linked to clinically meaningful sleep disturbance or daytime impairment and are not better explained by another disorder.

Most people with a clear RLS history do not need a sleep study solely to prove RLS. Testing may be useful when another sleep disorder—especially obstructive sleep apnea—or unusual movements are suspected.

Iron deserves special attention

Brain iron biology is closely tied to RLS. The 2025 American Academy of Sleep Medicine guideline advises regular iron studies in clinically significant RLS, including ferritin and transferrin saturation. The thresholds used in RLS are different from the usual definition of anemia, so a “normal” blood count does not settle the question.²

Do not start high-dose iron blindly. Oral or intravenous iron should be chosen from properly collected iron studies, medical history, tolerability and the clinical plan. Excess iron can be harmful.

What can make RLS worse?

Iron deficiency or blood loss, including heavy menstrual bleeding, gastrointestinal loss or frequent donation.
Pregnancy, kidney disease and some neurological conditions.
Alcohol, caffeine and sleep deprivation in susceptible people.
Selected medications, including sedating antihistamines, dopamine-blocking drugs and some serotonergic agents.
Untreated obstructive sleep apnea, which should be addressed as part of an integrated sleep evaluation.²

Treatment has changed

Good care begins by treating contributors: review medications, reduce aggravating substances, correct iron status when appropriate and address coexisting sleep disorders. For chronic persistent RLS, current guidance strongly supports alpha‑2‑delta ligands such as gabapentin, gabapentin enacarbil or pregabalin for appropriate adults.²

Dopamine agonists can reduce symptoms, but routine long-term use is no longer favored because of augmentation—a medication-induced worsening in which symptoms start earlier, become more intense, appear after less rest or spread to other body regions. Stopping these medications abruptly can also cause severe rebound, so changes should be supervised.

Severe refractory RLS may require specialist-directed combination therapy or carefully selected opioid treatment. The benefit-risk discussion is individualized and includes sedation, breathing, dependence and interaction risks. A 2026 updated management algorithm continues to emphasize iron assessment, gabapentinoids as first-line pharmacologic therapy, and precautions around dopamine agonists.⁴

How to prepare for an evaluation

Write down when symptoms begin, what they feel like and what makes them better.
Bring a complete medication and supplement list, including over-the-counter sleep or allergy products.
Note blood donation, heavy bleeding, pregnancy, kidney disease and family history of similar symptoms.
Describe snoring, witnessed apneas, insomnia and daytime sleepiness.

One-sided swelling, redness, warmth or persistent focal pain is not a typical RLS pattern and deserves prompt medical evaluation. New weakness, loss of sensation or difficulty walking also requires a neurological assessment.

The bottom line

RLS is a clinical diagnosis with a disciplined pattern: urge, rest, movement relief and evening predominance—plus the requirement that a mimic does not explain it better. The most useful next step is not simply a sleep aid. It is a targeted evaluation of the pattern, iron status, medications, sleep apnea and the person’s broader neurological and medical context.

References

Allen RP, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated IRLSSG consensus criteria. Sleep Medicine. 2014;15(8):860–873.
Winkelman JW, et al. Treatment of restless legs syndrome and periodic limb movement disorder: an AASM clinical practice guideline. Journal of Clinical Sleep Medicine. 2025;21(1):137–152.
American Academy of Sleep Medicine. Summary of the new clinical practice guideline for RLS and PLMD.
Silber MH, et al. An Updated Algorithm for the Management of Restless Legs Syndrome. Mayo Clinic Proceedings. 2026. doi:10.1016/j.mayocp.2026.05.010.

This article is educational and does not provide a diagnosis or individualized medical advice. Medication and iron decisions should be made with a qualified clinician after appropriate evaluation.